← News
Stocks· September 04, 2026 at 03:58 PM
This week in charts: China deals, stock flatlines and Lilly’s M&A spree - BioPharma Dive
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
This week in charts: China deals, stock flatlines and Lilly’s M&A spree BioPharma Dive
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
StocksMedium impactNeutral1h
Prediction: Vera Rubin Is About to Become a $20 Billion Windfall for Nvidia by Next Quarter
via Yahoo Finance
NVDA
StocksMedium impactNeutral1h
Stock Market Midday, Sept. 4: Stocks Edge Lower on Strong Jobs Report as Lululemon Plummets - fool.com
via fool.com
StocksMedium impactNeutral2h
Oura Revenue Surges as Smart-Ring Company Looks to Go Public. Apple Is a Risk.
via Yahoo Finance
AAPL
StocksMedium impactNeutral2h
Why Fair Isaac Stock Crashed Today
via Yahoo Finance
NVDA